Project Grant R01DA062622
Award Date
6/1/25
Completion Date
2/28/30
Dollars Obligated
$688K
Federal Agency
National Institute on Drug Abuse
Awardee
Yale Univ (FL6GV84CKN57)
Federal Grant Program
93.279
Assistance Type
Project Grant
Place of Performance
Connecticut, USA
Similar Awards
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Federal Grant Program "Drug Use and Addiction Research Programs" (CFDA 93.279), provides $1,607,146 over 2 years to NDRI-USA Inc., a non-profit research organization based in New York. The funding will support the development of technology-based interventions to encourage drug checking, distribution of harm reduction supplies, and linkage to substance use services. The project aims to address the...
This federal Project Grant award for $4,319,168.00, awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs), supports research to investigate the functional connectivity mechanisms of opioid abstinence. The award was granted to Yale University and aims to address the significant public health challenge of opioid use disorder (OUD), which has reached epidemic levels in recent years. The research will examine the neurological underpinnings of OUD...
The National Institute on Drug Abuse (NIDA) awarded a $266,742 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to Yale University to conduct a two-year qualitative study. The study aims to characterize transitions to low-frequency injecting and injection cessation among people using xylazine-adulterated fentanyl in Connecticut. The research objectives are to: 1) examine how exposure to xylazine-adulterated fentanyl intersects with social-structural factors to shape...
This $719,401 Project Grant from the National Institutes of Health (CFDA 93.310 Trans-NIH Research Support program) awarded to Yale University aims to develop and evaluate novel methods for predicting, detecting, and diagnosing outbreaks of HIV and other infectious diseases among people who use drugs. The key products and services to be delivered include: Prediction models and pattern recognition frameworks to forecast jurisdictions at high risk of emerging outbreaks; 2) Novel algorithms to...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to develop efficient statistical methods for data fusion to improve the power and external validity of clinical trials for treating opioid use disorder. The $564,326 award, with a performance period from August 2024 to May 2029, will fund the development of new parametric and semiparametric estimators for average treatment effects,...
This Project Grant award of $357,613 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to leverage large-scale whole-genome sequencing (WGS) datasets to identify novel rare and common genetic variants associated with substance use disorders (SUDs). Additionally, the study will develop a novel whole-genome multi-ancestry polygenic risk score framework to enhance disease prediction for SUDs. The research is expected to...
The National Institute on Drug Abuse (NIDA) awarded a $592,998 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The University of Texas at El Paso (UTEP) to conduct research on the role of striosomal circuitry in driving drug-taking behavior in the face of cost. The project aims to validate a computational model of costly drug-taking during craving states, using electrophysiology, optogenetics, and advanced modeling techniques to determine the impact of the...
The National Institute on Drug Abuse (NIDA) awarded a 5-year, $3,226,170 Project Grant under CFDA 93.279 (Drug Use and Addiction Research Programs) to the Lovelace Biomedical Research Institute in Albuquerque, NM. The grant funding will support a randomized clinical trial to evaluate the effectiveness of tailored cognitive skills training interventions for improving outcomes in offenders with substance use disorders. The project aims to match specific cognitive-emotional deficits exhibited by...
The National Institute on Drug Abuse (NIDA) awarded a $267,696 Project Grant (CFDA 93.279 - Drug Use and Addiction Research Programs) to the University of Massachusetts Lowell (UML) to establish the PHIT-AR (Addiction Research) track within its existing Public Health Informatics and Technology (PHIT) undergraduate program. The key objectives are to: 1) Expand the PHIT program to incorporate a new focus on applying data science skills to drug addiction research; 2) Recruit a diverse cohort of...
This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the Drug Use and Addiction Research Programs (CFDA 93.279), is providing $4,801,857 to Yale University to conduct research on the effects of different medications for opioid use disorder (MOUD) on the central nervous system of people living with HIV. The key objectives are to compare the impact of opioid antagonist (XR-naltrexone) versus opioid agonist (methadone, buprenorphine) MOUD treatments on...